Haemonetics' GAAP net income for fiscal year 2021 was $79.469 million, up 3.8% from $76.526 million in the prior year. Revenue declined 11.9% to $870.463 million from $988.479 million a year earlier.
Haemonetics' GAAP net income for fiscal year 2021 was $79.469 million, up 3.8% from $76.526 million in the prior year. Revenue declined 11.9% to $870.463 million from $988.479 million a year earlier. 
English (US) 